Fresenius Medical Care Ag · XETR:FME
Fresenius Medical Care — Investor Presentation (November 2021)
18 slides from Fresenius Medical Care's investor presentation, Nov 2, 2021
Slide 1: FME25 Conference Call
FME25 CONFERENCE CALL NOVEMBER 2, 2021 Rice Powell – CEO & Chairman Helen Giza – CFO & CTO © Copyright
Slide 2: Safe harbor statement
Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. Forward-looking statements are inherently subject to risks and uncert
Slide 3: Agenda
1 MID-TERM STRATEGY 2 FME25 AGENDA
Slide 4: Execution on Strategy 2025
FME25| EXECUTION ON STRATEGY 2025 RENAL CARE CONTINUUM CORE – DIALYSIS PRODUCTS AND SERVICES Dialysis Business, Value-Based Care Dialysis Services, Dialysis Products models, expansion along the renal Leverage expertise in Services, MedTech and patient journey in CKD and Pharma to maximize impact of
Slide 5: Strategy 2025 Driving Growth & Value
FME25| EXECUTION ON STRATEGY 2025 STRATEGY 2025 DRIVING GROWTH & VALUE OUR CORE COMPETENCIES − Creating value for patients, payors and FME while keeping care affordable by expansion of leading COORDINATING PATIENTS EFFICIENTLY value-based care business in dialysis and into new patient groups along t
Slide 6: Vertical Integration Globalized Operating Model
FME25| EXECUTION ON STRATEGY 2025 Vertical Integration Globalized Operating Model Patient Care Further leverage advantages of vertical integration in a globalized operating model that − enables capturing the identified growth opportunities − leverages expertise to accelerate value Engineering creati
Slide 7: Execution on Strategy 2025
FME25| EXECUTION ON STRATEGY 2025 Geographical expansion & market consolidation Next level of value creation Unlock value and drive future growth and Reorient the profitability business around strategic value Start of drivers transformation to a lean G&A model Start of global medical knowledge excha
Slide 8: Agenda
1 MID-TERM STRATEGY 2 FME25 AGENDA
Slide 9: Goals of FME25 to Create Shareholder Value
FME25| GOALS OF FME25 TO CREATE SHAREHOLDER VALUE CREATING A FUTURE WORTH LIVING. FOR PATIENTS. WORLDWIDE. EVERY DAY. Support execution of our 2025 strategy and deliver on mid- Invest up to €500m by 2025 to sustainably reduce the cost base term targets For each euro one-time investment improve annua
Slide 10: Current Operating Model and Limitations
FME25 | CURRENT OPERATING MODEL AND LIMITATIONS Decentralized regional approach during geographic OPERATING SEGMENTS expansion and market consolidation phase North Europe, Latin Asia Pacific − Vertical integration on a regional basis limits leveraging America Middle East America benefits to full ext
Slide 11: Future Operating Model to Strengthen Core
FME25 | FUTURE OPERATING MODEL TO STRENGTHEN CORE GLOBALIZED OPERATING MODEL DRIVING GROWTH & VALUE OPERATING SEGMENTS − Simplified globalized organization with end-to-end accountability drives transparency, enhances capital Care Delivery Care Enablement allocation, increases operational agility, en
Slide 12: Future Operating Model | Care Delivery
FME25 | FUTURE OPERATING MODEL | CARE DELIVERY Operating Segment Care Delivery − One global healthcare services operating segment implementing latest medical and scientific developments at global Commercial Operations scale, enhancing profitable growth while improving quality of care and affordabili
Slide 13: Future Operating Model | Care Enablement
FME25 | FUTURE OPERATING MODEL | CARE ENABLEMENT Operating Segment Care Enablement − Fully integrated MedTech segment focused on: − Accelerated innovation − Cost leadership Product Business Units − Commercial excellence Care In-Center Home Critical Care − Strategic capital allocation Enablement (Hea
Slide 14: Future Operating Model | G&A
FME25 | FUTURE OPERATING MODEL | G & A General & Administrative − New globalized operating model enables globalization of G&A functions HR, IT, Procurement, Legal, Compliance − Reduced organizational complexity, drive consistency via global standards and streamlined processes, increased Global funct
Slide 15: Transition to New Operating Model
FME25 | TRANSITION TO NEW OPERATING MODEL Q4 2021 2022 ~2023 Finalize operating model Transition to new operating Start new operating model and detail implementation plan model and new external reporting − Define and finalize governance Care Delivery & Care Enablement Revenue and operating income st
Slide 16: FME25 In Numbers
FME25| IN NUMBERS KEY FINANCIAL METRICS SAVINGS CATEGORIES (EXAMPLES) − Sustainable reduction of Care Clinic operations efficiency 2025 annual cost base by Delivery Standardize delivery models globally €500m Leverage best-in-class practices 50% of annual savings Real estate optimization ~2
Slide 17: Embedded in Strategy to Create Value
FME25| EMBEDDED IN STRATEGY TO CREATE VALUE STRATEGY 2025 GLOBAL OPERATING MODEL OPERATING SEGMENTS Care Delivery Care Enablement (Healthcare Services) (Healthcare Products) Global Medical Office General and Administrative FME25 Communication 11/2021 Page 17
Slide 18: Your Questions Are Welcome
ww wy FRESENIUS vy MEDICAL CARE YOUR QUESTIONS ARE WELCOME.
Fresenius Medical Care — Investor Presentation (November 2021) on 6ix